These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29508305)

  • 1. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
    Berger JR; Malik V; Lacey S; Brunetta P; Lehane PB
    J Neurovirol; 2018 Jun; 24(3):323-331. PubMed ID: 29508305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab utilization for approved and off-label nononcology indications and patients' experiences with the Patient Alert Card.
    Sarsour K; Beckley-Kartey S; Melega S; Odueyungbo A; Kirchner P; Khalife N; Bangs J
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00555. PubMed ID: 31911839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
    Verheyen J; Maizus K; Feist E; Tolman Z; Knops E; Saech J; Spengler L; Waterboer T; Burmester GR; Pawlita M; Pfister H; Rubbert-Roth A
    Med Microbiol Immunol; 2015 Oct; 204(5):613-8. PubMed ID: 25678083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy in autoimmune diseases.
    Palazzo E; Yahia SA
    Joint Bone Spine; 2012 Jul; 79(4):351-5. PubMed ID: 22281228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.
    Fleischmann RM
    Arthritis Rheum; 2009 Nov; 60(11):3225-8. PubMed ID: 19877057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab.
    Vermeer NS; Straus SM; Mantel-Teeuwisse AK; Hidalgo-Simon A; Egberts AC; Leufkens HG; De Bruin ML
    Clin Pharmacol Ther; 2015 Nov; 98(5):542-50. PubMed ID: 26347128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
    Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
    Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.
    Clifford DB; Ances B; Costello C; Rosen-Schmidt S; Andersson M; Parks D; Perry A; Yerra R; Schmidt R; Alvarez E; Tyler KL
    Arch Neurol; 2011 Sep; 68(9):1156-64. PubMed ID: 21555606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
    Merkel PA; Niles JL; Mertz LE; Lehane PB; Pordeli P; Erblang F
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1372-1378. PubMed ID: 32475029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE MECHANISMS OF ACTION OF RITUXIMAB].
    Gil'deeva GN; Kudlai DA; Luk'yanov SV
    Eksp Klin Farmakol; 2015; 78(12):51-6. PubMed ID: 27051930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.
    Jo JC; Jeon Y; Kim D; Yang DH; Lee WS; Choi YS; Yi JH; Yoon DH; Kong JH; Choe JY; Kim S; Ahn K; Park T; Ju H; Kwon S; Cho SG
    Expert Opin Biol Ther; 2023; 23(8):737-747. PubMed ID: 36757373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator.
    Kwon HC; Kim MK; Song JJ; Park YB; Lee SW
    Yonsei Med J; 2020 Aug; 61(8):712-719. PubMed ID: 32734735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
    Borie D; Kremer JM
    Semin Arthritis Rheum; 2015 Oct; 45(2):163-6. PubMed ID: 26190565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.
    Bennett CL; Focosi D; Socal MP; Bian JC; Nabhan C; Hrushesky WJ; Bennett AC; Schoen MW; Berger JR; Armitage JO;
    Lancet Haematol; 2021 Aug; 8(8):e593-e604. PubMed ID: 34329579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Singer O; McCune WJ
    Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments.
    Clavel G; Moulignier A; Semerano L
    Joint Bone Spine; 2017 Dec; 84(6):671-675. PubMed ID: 28323224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature.
    Pugnet G; Pagnoux C; Bézanahary H; Ly KH; Vidal E; Guillevin L
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S62-4. PubMed ID: 23663683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance and PML in the oncology setting.
    Bennett CL
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S13-7. PubMed ID: 22123927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis.
    Owczarczyk K; Cascino MD; Holweg C; Tew GW; Ortmann W; Behrens T; Schindler T; Langford CA; St Clair EW; Merkel PA; Spiera R; Seo P; Kallenberg CG; Specks U; Lim N; Stone J; Brunetta P; Prunotto M;
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.